Recent News

• 09.09.2025 - Baird 2025 Global Healthcare Conference
• 09.08.2025 - Morgan Stanley 23rd Annual Global Healthcare Conference
• 09.04.2025 - Cantor Global Healthcare Conference 2025
• 09.03.2025 - The LPAR1 antagonist, PIPE-791 produces antifibrotic effects in models of lung fibrosis
• 08.28.2025 - Contineum Therapeutics to Present at September Investor Conferences
• 08.05.2025 - Contineum Therapeutics Reports Second-Quarter 2025 Financial Results; Updates Key Clinical Development Milestones

Recent Filings

• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.05.2025 - 8-K Current report
• 08.05.2025 - EX-99.1 EX-99.1
• 08.05.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.05.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 07.25.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 06.26.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.26.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.26.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.26.2025 - 4 Statement of changes in beneficial ownership of securities